N-Methyl-1-deoxynojirimycin



Compound IDCDAMM00977
Common nameN-Methyl-1-deoxynojirimycin
IUPAC name2-(hydroxymethyl)-1-methylpiperidine-3,4,5-triol
Molecular formulaC7H15NO4

Experimental data

Retention time0.43
Adduct[M+K]+
Actual mz216.062
Theoretical mz216.063
Error3.97
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.6872

Identifiers and class information

Inchi keyAAKDPDFZMNYDLR-UHFFFAOYNA-N
SmilesOCC1N(C)CC(O)C(O)C1O
SuperclassOrganoheterocyclic compounds
ClassPiperidines

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)177.2
Computed dipole moment(dipole)2.599
Total solvent accessible surface area (SASA)365.031
Hydrophobic component of SASA (FOSA)203.399
Hydrophilic component of SASA (FISA)161.632
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)606.461
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)8.8
Free energy of solvation of dipole (dip^2/V)0.0111412
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0482151
Globularity descriptor (glob)0.949229
Predicted polarizability in cubic angstroms (QPpolrz)14.906
Predicted hexadecane/gas partition coefficient (QPlogPC16)6.364
Predicted octanol/gas partition coefficient (QPlogPoct)15.057
Predicted water/gas partition coefficient (QPlogPw)15.12
Predicted octanol/water partition coefficient (QPlogPo/w)-1.74
Predicted aqueous solubility (QPlogS)0.293
Conformation-independent predicted aqueous solubility (CIQPlogS)0.645
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.08
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)72.451
Predicted brain/blood partition coefficient (QPlogBB)-0.535
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)32.068
Predicted skin permeability, log Kp (QPlogKp)-6.081
PM3 calculated ionization potential (IP(ev))9.358
PM3 calculated electron affinity (EA(eV))-1.894
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-0.835
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)50.046
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)90.052
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P11940PABPC1Polyadenylate-binding protein 1T58679SwissTargetPrediction
O00754MAN2B1Lysosomal alpha-mannosidaseT63156SwissTargetPrediction and SEA
P06280GLAAlpha-galactosidase AT61339SwissTargetPrediction
P14555PLA2G2APhospholipase A2 group IIAT19160SwissTargetPrediction
P04054PLA2G1BPhospholipase A2 group 1BT31479SwissTargetPrediction
P48449LSSLanosterol synthaseT56175SwissTargetPrediction
P16278GLB1Beta-galactosidase (by homology)T73134SwissTargetPrediction and SEA
Q16739UGCGCeramide glucosyltransferaseT14908SwissTargetPrediction and SEA
O43451MGAMMaltase-glucoamylaseT92777SwissTargetPrediction
P10253GAALysosomal alpha-glucosidase (by homology)T31514SwissTargetPrediction and SEA
P06280GLAAlpha-galactosidase AT61339SwissTargetPrediction
P06280GLAAlpha-galactosidase AT61339SwissTargetPrediction and SEA
P04062GBABeta-glucocerebrosidaseT84173SwissTargetPrediction
P06737PYGLLiver glycogen phosphorylaseT19184SwissTargetPrediction
Q9UMJ8GBA1Lysosomal acid glucosylceramidaseT63243SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T58679DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P11940PABPC1
T63156DI0242Lysosomal disease[ICD-11: 5C56]O00754MAN2B1
T61339DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]P06280GLA
T19160DI0062Breast cancer[ICD-11: 2C60-2C6Y]P14555PLA2G2A
T31479DI0230Leishmaniasis[ICD-11: 1F54]P04054PLA2G1B
T31479DI0335Peroxisomal disease[ICD-11: 5C57]P04054PLA2G1B
T31479DI0367Rosacea[ICD-11: ED90]P04054PLA2G1B
T31479DI0398Synthesis disorder[ICD-11: 5C52-5C59]P04054PLA2G1B
T56175DI0035Arterial occlusive disease[ICD-11: BD40]P48449LSS
T73134DI0242Lysosomal disease[ICD-11: 5C56]P16278GLB1
T14908DI0242Lysosomal disease[ICD-11: 5C56]Q16739UGCG
T14908DI0257Metabolic disorder[ICD-11: 5C50-5D2Z]Q16739UGCG
T92777DI0009Acute diabete complication[ICD-11: 5A2Y]O43451MGAM
T92777DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]O43451MGAM
T31514DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]P10253GAA
T61339DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]P06280GLA
T61339DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]P06280GLA
T84173DI0257Metabolic disorder[ICD-11: 5C50-5D2Z]P04062GBA
T63243DI0242Lysosomal disease[ICD-11: 5C56]Q9UMJ8GBA1

Copyright © 2025